(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.41%) $78.06
(0.23%) $2.21
(-0.32%) $2 316.70
(-0.67%) $27.36
(-0.30%) $985.40
(0.18%) $0.931
(0.43%) $10.95
(0.18%) $0.801
(-0.01%) $91.44
-3.32% £ 32.00
Live Chart Being Loaded With Signals
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products...
Stats | |
---|---|
Dzisiejszy wolumen | 4.44M |
Średni wolumen | 1.01M |
Kapitalizacja rynkowa | 172.93M |
EPS | £0 ( 2024-04-09 ) |
Last Dividend | £1.184 ( 2023-06-22 ) |
Next Dividend | £0 ( N/A ) |
P/E | -32.00 |
ATR14 | £0.0570 (0.18%) |
Wolumen Korelacja
Alliance Pharma PLC Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RCN.L | 0.919 |
XUEB.L | 0.905 |
BIRG.L | 0.905 |
AIBG.L | 0.902 |
FOG.L | 0.896 |
EBQ.L | 0.885 |
NUM.L | 0.883 |
DTY.L | 0.881 |
EMAU.L | 0.871 |
CLIN.L | 0.867 |
10 Najbardziej negatywne korelacje | |
---|---|
TEP.L | -0.906 |
3NIS.L | -0.896 |
LNGA.L | -0.885 |
GFIN.L | -0.884 |
INHC.L | -0.882 |
PTRO.L | -0.882 |
GIF.L | -0.882 |
BIDS.L | -0.878 |
ECHO.L | -0.872 |
PUR.L | -0.871 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Alliance Pharma PLC Korelacja - Waluta/Towar
Alliance Pharma PLC Finanse
Annual | 2022 |
Przychody: | £167.42M |
Zysk brutto: | £101.68M (60.74 %) |
EPS: | £0.00170 |
FY | 2022 |
Przychody: | £167.42M |
Zysk brutto: | £101.68M (60.74 %) |
EPS: | £0.00170 |
FY | 2021 |
Przychody: | £163.21M |
Zysk brutto: | £109.45M (67.06 %) |
EPS: | £0.0137 |
FY | 2020 |
Przychody: | £129.80M |
Zysk brutto: | £82.82M (63.80 %) |
EPS: | £0.0154 |
Financial Reports:
No articles found.
Alliance Pharma PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0.592 (N/A) |
£0 (N/A) |
£1.184 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £0.0700 | 2009-12-02 |
Last Dividend | £1.184 | 2023-06-22 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 28 | -- |
Total Paid Out | £15.63 | -- |
Avg. Dividend % Per Year | 1.27% | -- |
Score | 3.3 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 3.44 | |
Div. Directional Score | 5.03 | -- |
Year | Amount | Yield |
---|---|---|
2009 | £0.0700 | 2.33% |
2010 | £0.400 | 1.48% |
2011 | £0.650 | 2.11% |
2012 | £0.775 | 2.51% |
2013 | £0.853 | 2.67% |
2014 | £0.938 | 2.32% |
2015 | £1.033 | 2.79% |
2016 | £1.137 | 2.65% |
2017 | £1.250 | 2.75% |
2018 | £1.375 | 2.04% |
2019 | £1.513 | 2.30% |
2020 | £0.536 | 0.63% |
2021 | £2.20 | 2.50% |
2022 | £1.720 | 1.57% |
2023 | £1.184 | 2.17% |
2024 | £0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
STM.L | Dividend Knight | 2023-08-31 | Semi-Annually | 17 | 2.49% | |
JLEN.L | Dividend King | 2023-08-31 | Quarterly | 11 | 366.93% | |
CAM.L | Dividend Junior | 2023-09-14 | Annually | 32 | 1.66% | |
PSHD.L | No Dividend Player | 2023-08-17 | Annually | 6 | 0.41% | |
GBG.L | Dividend Junior | 2023-06-22 | Annually | 22 | 0.51% | |
AGT.L | Dividend Knight | 2023-06-15 | Semi-Annually | 47 | 0.85% | |
TON.L | Dividend Knight | 2023-06-01 | Annually | 32 | 1.80% | |
LTHM.L | Dividend Knight | 2023-08-03 | Semi-Annually | 33 | 0.87% | |
COA.L | Dividend Knight | 2023-10-19 | Annually | 33 | 1.79% | |
ROR.L | Dividend Knight | 2023-08-17 | Semi-Annually | 32 | 1.43% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0415 | 1.500 | -0.830 | -1.245 | [0 - 0.5] |
returnOnAssetsTTM | -0.0137 | 1.200 | -0.458 | -0.550 | [0 - 0.3] |
returnOnEquityTTM | -0.0250 | 1.500 | -1.389 | -2.08 | [0.1 - 1] |
payoutRatioTTM | -1.315 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.931 | 0.800 | 5.35 | 4.28 | [1 - 3] |
quickRatioTTM | 1.333 | 0.800 | 6.86 | 5.49 | [0.8 - 2.5] |
cashRatioTTM | 0.533 | 1.500 | 8.15 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.242 | -1.500 | 5.96 | -8.94 | [0 - 0.6] |
interestCoverageTTM | 3.05 | 1.000 | 9.98 | 9.98 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0402 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0397 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.449 | -1.500 | 8.20 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.516 | 1.000 | 4.74 | 4.74 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.144 | 1.000 | 9.13 | 9.13 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.174 | 1.000 | -0.143 | -0.143 | [0.2 - 2] |
assetTurnoverTTM | 0.331 | 0.800 | -1.127 | -0.901 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -25.32 | 1.000 | -2.66 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0250 | 2.50 | -0.893 | -2.08 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0397 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.58 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0402 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | -1.315 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | 87.66 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.128 | 1.000 | 9.31 | 0 | [0.1 - 0.5] |
Total Score | 3.44 |
Alliance Pharma PLC
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej